Page last updated: 2024-08-17

isosorbide dinitrate and 11-dehydro-thromboxane b2

isosorbide dinitrate has been researched along with 11-dehydro-thromboxane b2 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andersson, A; Hjemdahl, P; Wallén, NH	1
del Soldato, P; Fiorucci, S; Lechi, A; Mencarelli, A; Meneguzzi, A; Minuz, P; Morelli, A	1

Trials

1 trial(s) available for isosorbide dinitrate and 11-dehydro-thromboxane b2

Article	Year
Effects of treatment with oral isosorbide dinitrate on platelet function in vivo; a double-blind placebo-controlled study in patients with stable angina pectoris. British journal of clinical pharmacology, 1994, Volume: 38, Issue:1 Topics: Administration, Oral; Aged; Angina Pectoris; beta-Thromboglobulin; Blood Platelets; Creatinine; Cross-Over Studies; Double-Blind Method; Exercise Test; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Patient Compliance; Platelet Aggregation; Thromboxane B2	1994

Article

Year

Effects of treatment with oral isosorbide dinitrate on platelet function in vivo; a double-blind placebo-controlled study in patients with stable angina pectoris.

British journal of clinical pharmacology, 1994, Volume: 38, Issue:1

Topics: Administration, Oral; Aged; Angina Pectoris; beta-Thromboglobulin; Blood Platelets; Creatinine; Cross-Over Studies; Double-Blind Method; Exercise Test; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Patient Compliance; Platelet Aggregation; Thromboxane B2

1994

Other Studies

1 other study(ies) available for isosorbide dinitrate and 11-dehydro-thromboxane b2

Article	Year
NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide. Circulation, 2002, 12-10, Volume: 106, Issue:24 Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blotting, Western; Cyclooxygenase 2; Cysteine Proteinase Inhibitors; Drug Administration Schedule; Flow Cytometry; Gastric Mucosa; Interleukin-1; Isoenzymes; Isosorbide Dinitrate; Male; Monocytes; Nitric Oxide; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thromboplastin; Thromboxane B2; Tumor Necrosis Factor-alpha	2002

Article

Year

NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide.

Circulation, 2002, 12-10, Volume: 106, Issue:24

Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blotting, Western; Cyclooxygenase 2; Cysteine Proteinase Inhibitors; Drug Administration Schedule; Flow Cytometry; Gastric Mucosa; Interleukin-1; Isoenzymes; Isosorbide Dinitrate; Male; Monocytes; Nitric Oxide; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thromboplastin; Thromboxane B2; Tumor Necrosis Factor-alpha

2002